XGN
Income statement / Annual
Last year (2024), Exagen Inc.'s total revenue was $55.64 M,
an increase of 5.89% from the previous year.
In 2024, Exagen Inc.'s net income was -$15.12 M.
See Exagen Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$55.64 M |
$52.55 M |
$45.56 M |
$48.30 M |
$41.98 M |
$40.39 M |
$32.44 M |
$26.81 M |
$17.95 M |
$11.66 M |
| Cost of Revenue |
$22.53 M
|
$23.09 M
|
$24.21 M
|
$20.59 M
|
$16.56 M
|
$18.81 M
|
$15.38 M
|
$14.14 M
|
$9.53 M
|
$6.89 M
|
| Gross Profit |
$33.11 M
|
$29.46 M
|
$21.35 M
|
$27.71 M
|
$25.42 M
|
$21.58 M
|
$17.06 M
|
$12.67 M
|
$8.41 M
|
$4.78 M
|
| Gross Profit Ratio |
0.6
|
0.56
|
0.47
|
0.57
|
0.61
|
0.53
|
0.53
|
0.47
|
0.47
|
0.41
|
| Research and Development Expenses |
$5.38 M
|
$4.87 M
|
$9.88 M
|
$7.24 M
|
$3.57 M
|
$2.18 M
|
$2.13 M
|
$1.55 M
|
$1.37 M
|
$1.29 M
|
| General & Administrative Expenses |
$0.00
|
$45.93 M
|
$49.02 M
|
$42.84 M
|
$35.73 M
|
$27.10 M
|
$18.28 M
|
$17.52 M
|
$15.91 M
|
$13.97 M
|
| Selling & Marketing Expenses |
$0.00
|
$1.50 M
|
$3.00 M
|
$1.70 M
|
$1.30 M
|
$1.60 M
|
$1.40 M
|
$1.30 M
|
$1.50 M
|
$1.10 M
|
| Selling, General & Administrative Expenses |
$41.37 M
|
$47.43 M
|
$52.02 M
|
$44.54 M
|
$37.03 M
|
$28.70 M
|
$19.68 M
|
$18.82 M
|
$17.41 M
|
$15.07 M
|
| Other Expenses |
$0.00
|
$0.00
|
$5.51 M
|
$16,000.00
|
$984,000.00
|
$510,000.00
|
$141,000.00
|
$186,000.00
|
$1.22 M
|
-$497,000.00
|
| Operating Expenses |
$46.75 M
|
$52.29 M
|
$61.89 M
|
$51.78 M
|
$40.60 M
|
$30.88 M
|
$21.94 M
|
$20.56 M
|
$19.07 M
|
$16.57 M
|
| Cost And Expenses |
$69.28 M
|
$75.39 M
|
$86.11 M
|
$72.37 M
|
$57.16 M
|
$49.69 M
|
$37.32 M
|
$34.69 M
|
$28.60 M
|
$23.46 M
|
| Interest Income |
$767,000.00
|
$1.52 M
|
$830,000.00
|
$16,000.00
|
$2.28 M
|
$2.98 M
|
$112,000.00
|
$45,000.00
|
$0.00
|
$0.00
|
| Interest Expense |
$2.23 M
|
$2.34 M
|
$2.45 M
|
$2.63 M
|
$2.57 M
|
$3.49 M
|
$2.87 M
|
$2.95 M
|
$4.50 M
|
$2.94 M
|
| Depreciation & Amortization |
$1.72 M
|
$2.17 M
|
$2.11 M
|
$948,000.00
|
$546,000.00
|
$591,000.00
|
$731,000.00
|
$670,000.00
|
$879,000.00
|
$558,000.00
|
| EBITDA |
-$13.64 M |
-$19.15 M |
-$43.11 M |
-$23.10 M |
-$13.66 M |
-$7.93 M |
-$4.36 M |
-$22.56 M |
-$13.55 M |
-$11.50 M |
| EBITDA Ratio |
-0.25
|
-0.36
|
-0.87
|
-0.5
|
-0.34
|
-0.22
|
-0.12
|
-0.27
|
-0.48
|
-1.01
|
| Operating Income Ratio |
-0.25
|
-0.43
|
-0.89
|
-0.5
|
-0.36
|
-0.23
|
-0.15
|
-0.29
|
-0.58
|
-0.99
|
| Total Other Income/Expenses Net |
-$1.47 M
|
-$819,000.00
|
-$1.62 M
|
-$2.61 M
|
-$1.58 M
|
-$2.71 M
|
-$3.07 M
|
-$18.34 M
|
-$8.54 M
|
-$3.44 M
|
| Income Before Tax |
-$15.10 M
|
-$23.66 M
|
-$47.67 M
|
-$26.68 M
|
-$16.77 M
|
-$12.01 M
|
-$7.95 M
|
-$26.18 M
|
-$18.93 M
|
-$14.99 M
|
| Income Before Tax Ratio |
-0.27
|
-0.45
|
-1.05
|
-0.55
|
-0.4
|
-0.3
|
-0.25
|
-0.98
|
-1.05
|
-1.29
|
| Income Tax Expense |
$12,000.00
|
$33,000.00
|
-$282,000.00
|
$175,000.00
|
-$79,000.00
|
$25,000.00
|
$58,000.00
|
-$549,000.00
|
$253,000.00
|
-$13,000.00
|
| Net Income |
-$15.12 M
|
-$23.69 M
|
-$47.39 M
|
-$26.85 M
|
-$16.69 M
|
-$12.04 M
|
-$8.01 M
|
-$25.63 M
|
-$19.18 M
|
-$14.98 M
|
| Net Income Ratio |
-0.27
|
-0.45
|
-1.04
|
-0.56
|
-0.4
|
-0.3
|
-0.25
|
-0.96
|
-1.07
|
-1.28
|
| EPS |
-0.83 |
-1.34 |
-2.77 |
-1.68 |
-1.32 |
-0.96 |
-127.16 |
-406.81 |
-305.48 |
-265.79 |
| EPS Diluted |
-0.83 |
-1.34 |
-2.77 |
-1.68 |
-1.32 |
-0.96 |
-127.16 |
-406.81 |
-305.48 |
-265.79 |
| Weighted Average Shares Out |
$18.20 M
|
$17.68 M
|
$17.08 M
|
$15.97 M
|
$12.65 M
|
$12.56 M
|
$63,005.00
|
$63,005.00
|
$62,797.00
|
$56,364.00
|
| Weighted Average Shares Out Diluted |
$18.20 M
|
$17.68 M
|
$17.08 M
|
$15.97 M
|
$12.65 M
|
$12.56 M
|
$63,005.00
|
$63,005.00
|
$62,797.00
|
$56,364.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
